South Korea Percutaneous Coronary Intervention Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, and Accessories), By Vascular Access (Radial and Femoral), and South Korea Percutaneous Coronary Intervention Market Insights, Industry Trend, Forecasts to 2035

South Korea Percutaneous Coronary Intervention Market Insights Forecasts to 2035

• The South Korea Percutaneous Coronary Intervention Market Size was Estimated at USD 236.0 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.89% from 2025 to 2035
• The South Korea Percutaneous Coronary Intervention Market Size is Expected to Reach USD 491.0 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Percutaneous Coronary Intervention Market Size is Anticipated to Reach USD 491.0 Million by 2035, Growing at a CAGR of 6.89% from 2025 to 2035. Increasing as a result of cardiovascular disease's increased prevalence, particularly in the elderly population. Technology developments like robotic-assisted PCI systems and drug-eluting stents that enhance procedural results and recovery times, as well as government programs encouraging early intervention, further support growth.

Market Overview

The South Korea percutaneous coronary intervention (PCI) market refers to the domestic landscape of minimally invasive procedures used to treat coronary artery disease by restoring blood flow through catheter-based techniques is referred to as the South Korean percutaneous coronary intervention (PCI) market. Additionally, the government has taken the initiative to strengthen the healthcare system, promote treatment alternatives, and support early intervention techniques. This emphasis on improving heart health is exemplified by initiatives that support the use of PCI technology, which is crucial in reducing the risk of serious cardiovascular events. Moreover, opportunities abound in the South Korean PCI market, particularly in the development and introduction of specialized devices for patients with complex diabetes or coronary artery disease. Further, government investments in health technology have led to an increase in the significance of collaborations between healthcare organizations and device manufacturers, allowing for the introduction of innovative solutions.

Report Coverage

This research report categorizes the market for the South Korea percutaneous coronary intervention market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea percutaneous coronary intervention market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea percutaneous coronary intervention market.

Driving Factors

The market for percutaneous coronary intervention in South Korea is fueled by the country's aging population, increasing demand for minimally invasive procedures, and the rising prevalence of cardiovascular diseases. Patient outcomes are being improved and procedural efficiency is being accelerated through the use of digital follow-up tools, government support for early intervention, and the adoption of cutting-edge technologies like robotic PCI systems and drug-eluting stents.

Restraining Factors

South Korea's PCI market is constrained by complicated regulations, high device costs, and limited reimbursement policies. Furthermore, despite the growing prevalence of cardiovascular disease and technological advancements, widespread implementation is hampered by uneven access in rural areas, a lack of qualified interventional cardiologists, and a slow adoption of robotic systems.

Market Segmentation

The South Korea percutaneous coronary intervention market share is classified into product type and vascular access.

• The coronary stents segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea percutaneous coronary intervention market is segmented by product type into coronary stents, balloon catheters, coronary guidewires, guiding catheters, guiding sheaths, diagnostic catheters, crossing catheters, inflation device, guidance system, peripheral thrombectomy system, embolic protection system, and accessories. Among these, the coronary stents segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Coronary Stents are essential as they lower the risk of restenosis by providing the structural support needed to keep arteries open after a PCI procedure.

• The radial segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea percutaneous coronary intervention market is segmented by vascular access into radial and femoral. Among these, the radial segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. preferred for patient comfort, quicker recovery, and fewer complications.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea percutaneous coronary intervention market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• LN Robotics
• Osstem Cardiology
• Medtronic Korea
• Boston Scientific Korea
• Terumo Korea
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Percutaneous Coronary Intervention Market based on the below-mentioned segments:

South Korea Percutaneous Coronary Intervention Market, By Product Type

• Coronary Stents
• Ballon Catheters
• Coronary Guidewires
• Guiding Catheters
• Guiding Sheaths
• Diagnostic Catheters
• Crossing Catheters
• Inflation Device
• Guidance System
• Peripheral Thrombectomy System
• Embolic Protection System
• Accessories

South Korea Percutaneous Coronary Intervention Market, By Vascular Access

• Radial
• Femoral